Zydus Wellness Q1FY26 – Sugar-Free Monopoly, 47x P/E, UK Acquisition Binge, and GST Discounts: Health Food or Junk Valuation?
1. At a Glance
Zydus Wellness is the FMCG cousin who shows up at the family reunion with Sugar Free in one hand, Glucon-D in the other, and Complan tucked under the arm — reminding everyone, “I own 93.9% of India’s sugar-substitute market.” Market cap? ₹15,073 crore. Current price? ₹474. Stock P/E? 46.8x — as if investors believe stevia leaves are the new Bitcoin. ROE? A lazy 6%. ROCE? 6.1% — even your savings account looks ambitious compared to that.
Quarterly sales are ₹861 crore with PAT of ₹128 crore (down 13.4% YoY). Operating margins hover around 14%. The company is debt-light at ₹188 crore, but cash flows are tighter than your jeans post-Diwali.
So, the real question: is Zydus Wellness the FMCG moat with brand leadership, or is it selling over-sweetened promises at premium valuations?
2. Introduction
Zydus Wellness operates like a Bollywood multi-starrer — Sugar Free, Everyuth, Complan, Glucon-D, Nycil, Nutralite — each brand a hit in its own category. It’s the kind of portfolio HUL would salivate over but politely decline because margins are too thin for their taste.
But behind the shiny ads featuring Madhuri Dixit and Sanjeev Kapoor lies a reality check: sales growth of ~9% CAGR in 5 years and ROE stuck at 6%. Investors paying Nestlé-like valuations for Zydus Wellness must be high on glucose powder.
And if you thought acquisitions are a solution — they just dropped ₹239 million GBP (₹2,400+ crore equivalent) on UK-based Comfort Click, after already buying Naturell (Ritebite protein snacks) last year. They’re clearly on a protein diet, but profits are on a low-carb plan.
Do you think FMCG players should binge on M&A abroad or fix their digestion at home first?
3. Business Model – WTF Do They Even Do?
In short: Zydus Wellness makes your chai sugar-free, your face acne-free, and your summer body glucose-full.
Health & Nutrition (Glucon-D, Complan, Sugar-Free, Nutralite, RiteBite Max Protein): From glucose powders to protein chips, they own the pantry of “guilt-free indulgence.”
Personal Care (Everyuth, Nycil): Everyuth dominates facial scrubs and peel-off masks (46% and 77% market share respectively). Nycil rules summer with a 34% share in prickly heat powders.
Business split: Food & Nutrition ~70%, Personal Care ~30%.
Fun fact: E-commerce sales have jumped from 4% in FY21 to 12.5% in FY25. Basically, Gen Z is buying Sugar Free sachets online the same way they order vape refills.
4. Financials Overview
Metric
Latest Qtr (Jun’25)
YoY Qtr (Jun’24)
Prev Qtr (Mar’25)
YoY %
QoQ %
Revenue
₹861 Cr
₹841 Cr
₹913 Cr
+2.4%
-5.7%
EBITDA
₹156 Cr
₹155 Cr
₹190 Cr
+0.6%
-17.9%
PAT
₹128 Cr
₹148 Cr
₹172 Cr
-13.4%
-25.6%
EPS (₹)
4.0
4.6
5.4
-13.0%
-25.9%
Annualised EPS = ~₹16. CMP/EPS = 29.6x, not 46.8x (screeners use trailing). Still expensive for a company growing single digits.
Commentary: Revenues crawling, profits sliding. This is like paying IPL ticket rates for a Ranji match.
